| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8944317 | American Heart Journal | 2018 | 34 Pages |
Abstract
HF patients with clinically significant SMR who continue to be symptomatic despite optimal GDMT have limited treatment options and a poor prognosis. The randomized COAPT trial was designed to determine the safety and effectiveness of transcatheter MV repair with the MitraClip in symptomatic HF patients with moderate-to-severe or severe SMR.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael J. MD, William T. MD, JoAnn MD, Steven F. MD, Ted E. MD, Paul A. MD, Samir R. MD, Patrick M. MD, D. Scott MD, James E. MD, Michael R. MD, James S. MD, A. Marc MD, Donald D. MD, David A. MD, Rakesh M. MD, Jeffrey T. PhD, Yu PhD, Gregg W. MD,